3D Genomics: The Next Dimension of Discovery

Using 3D genomics to harness the full potential of the human genome to enhance patient diagnosis and treatment

Demonstrating accelerated timelines for target identification and prioritisation, increasing confidence in biological rationale hence defining cell type focus in disease conditions, and ultimately revealing novel genomic biomarkers and an ability to differentiate responders versus non-responders during clinical development.

Using 3D genomics results in accelerated, cost-effective and enhanced drug discovery by revealing higher confidence targets, repurposing opportunities and patient stratification

Enhanced Genomics is building a comprehensive Human 3D Genome Atlas that will bring a new perspective to drug discovery

Actively seeking out partnership and collaboration opportunities to empower pharma and biotechs to utilise 3D genomics as a critical part of decision making in their part of their discovery drug development pipelines